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• Parenteral nutrition (PN) is an intravenous method of
feeding a patient that bypasses the gastrointestinal tract.

Patients who had PN orders from January 1st, 2019 to July 19th,
2021 (n=115)

Nutrition (ASPEN) has published guidelines for the
proper initiation of PN because they are high-alert
medications that can cause patient harm if misused1.

Patients who did not have PN
administered (n=6)

• The decision to initiate PN in patients should be clinically

The objective of this study is to to determine the
appropriate initiation of PN according to ASPEN guidelines
within the WellStar North Fulton campus.

• During the study time period, a total of 45 patients out of
109 were found to have an inappropriate use of PN per
ASPEN criteria (41.3%).

Figure 1. Patient selection

• The American Society for Parenteral and Enteral

evaluated, as patients who receive PN inappropriately
are at risk of complications such as increased risk of
infection, metabolic complications related to overfeeding
and refeeding, and increased possibility of other errors
during preparation or transcription of PN2,3.
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Patients who did have PN
administered (n =109)

Patients who did not receive
appropriate PN (n =45)

Patients who received appropriate PN
(n =64)

Table 1. Baseline characteristics

Gender, n (%)

Mean age, years,
(SD)

Female: 59 (54%)
Male: 56 (46%)

• Missing information in the electronic health record led to
uncertain classification of appropriateness in 6 patients.
These patients were marked as having an appropriate
indication, therefore the overall results are skewed
towards being more appropriate. If these patients would
be counted as inappropriate, the results would indicate
a higher rate of inappropriate use of PN (46.7%).

Mean duration of PN, days (SD)

66.3 (17.8)

• The most common reasons for inappropriate use of PN
was inappropriate duration (48.0%), timing (35.6%), and
indication (31.3%). Additionally, a significant amount of
patients had multiple reasons for inappropriate use
(28.9%).
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Figure 2. PN Indications

• Other PN indications in Figure 2 include
nausea/vomiting, necrotic bowel, diverticulitis, acute
pancreatitis, gastric perforations and colovesical fistula
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Inclusion Criteria:

• The average PN length was 7.5 days. Amongst patients
who had received inappropriate PN, the average PN
length was 4.0 days.
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• Patients ≥ 18 years of age
• All patients who had PN orders from January 1st, 2019
to July 19th, 2021
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• There was a total of 808 days of PN administered
during the time period with 217 of these days being
classified as inappropriate per ASPEN criteria. This
equates to a total loss of between $10,839-$13,775 due
to inappropriate use of PN.

Exclusion Criteria:
• Patients < 18 years of age
• Patients who had not received PN
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Figure 3. Inappropriate Use of PN per ASPEN criteria
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Data Collected:

Number of Patients
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• Patient demographics: age, gender, admission date, PN
administration date and duration
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• Appropriate use assessment:
o Indication
o Nutritional Status (malnourished/risk of malnutrition)
o Enteral nutrition status
o Timing and duration of PN
o Clinical appropriateness
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• Previous single-center studies have shown that
prescriber education and order entry restrictions
resulted in increased rates of appropriate PN
administration4. In conclusion we recommend prescriber
education by the pharmacy staff and implementation of
order entry restrictions in order to improve the
appropriate initiation of PN.
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